To explore feasibility of intraluminal oxygen administration at the site of the anastomosis in patients who underwent an esophagectomy.
ID
Source
Brief title
Condition
- Gastrointestinal neoplasms malignant and unspecified
- Gastrointestinal therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- To assess the successful placement of the intervention nasogastric oxygen
delivery tube.
- To assess the tolerance and feasibility of the intervention nasogastric
oxygen delivery tube for oxygen administration during the first 5 days after
surgery.
- To assess the amount of discomfort patients have of the extra nasogastric
tube.
- To monitor the intraluminal pressure via the oxygen delivery tube and
keep it under 20 mmHg
Secondary outcome
- To explore the safety of the administration of intraluminal oxygen via an
extra nasogastric tube at the site of the anastomosis in patients who underwent
an esophagectomy (bleeding, gastric tube distention).
- To what extent does the administration of intraluminal oxygen at the site of
the anastomosis effect theanastomotic leak rate in patients who underwent an
esophagectomy?(normal rate 20%)
Background summary
Anastomotic leakage is a severe complication after esophagectomy and causes
high morbidity and mortality. Unfortunately, anastomotic leakage still occurs
in 20% of patients after an esophagectomy. The leakage of the anastomosis is
frequently caused by local ischemia of the gastric conduit postoperative.
Various methods have been tested in order to decrease the occurrence of
anastomotic leakage. None of these methods has been successful in reducing the
occurrence in a major manner. There is however a potential novel solution to
this problem, which is the intraluminal administration of oxygen at the site of
the anastomosis. This intraluminal oxygen diffuses into mucosa to prevent
ischemia, and also stimulate tissue regeneration. It is, however, unknown if
this oxygen administration might be harmful to patients after an esophagectomy.
Study objective
To explore feasibility of intraluminal oxygen administration at the site of the
anastomosis in patients who underwent an esophagectomy.
Study design
Pilot feasibility study.
Intervention
Introduction of an additional nasogastric tube at the site of the anastomosis.
In 3 patients assessment of the pressure in the esophagus.
In the next 10 patients oxygen delivery through the nasogastric tube with the
addition of a pressure valve system that will be set on a safe pressure,
probably 20 mmHg.
This amendement is for the inclusion of an additional 6 patients. After
inclusion of the first 13 patients, the results are that the placement of the
intervention nasogastric oxygen delivery tube is feasible and safe. In addition
to this we also measured the intraluminal pressure of the esophagus and gastric
tube near the anastomosis and we only saw a pressure that was always below 20
mm Hg. Therefore we would like to include another 6 patients and give a little
bit more oxygen and see the effect on the intraluminal pressure. In an
additional 3 patients we would like to give 2 ml of oxygen per minute and in
another 3 patients 4 ml of oxygen per minute. After the first of these
additional 3 patients we will check for all primairy and secondairy endpoints
and check for the intraluminal pressure.
Study burden and risks
The subjects can have benefit participating in this study. There are risks
present, but it is expected that these risks are surmountable or reversible.
Furthermore, the outcome of this study can greatly improve the knowledge on the
prevention of anastomotic leakage, not limited to leakages after
esophagectomies.
Hanzeplein 1
Groningen 9700RB
NL
Hanzeplein 1
Groningen 9700RB
NL
Listed location countries
Age
Inclusion criteria
- Patients with esophageal cancer scheduled for a minimal invasive esophageal
resection with an intrathoracic anastomosis
- Aged 18 years or older.
- Signed informed consent.
Exclusion criteria
- Known nasopharynx abnormalities preventing nasogastric tube insertion
- Salvage surgery after *definitive chemo-radiotherapy*
- Unable to provide informed consent
- Patient being illiterate
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL69801.042.19 |
Other | NL8026 |